1-20 of 157
Philippe Armand
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
×Close Modal
Sort by
Journal Articles

The microenvironmental niche in classic Hodgkin lymphoma is enriched for CTLA-4- positive T-cells that are PD-1-negative

Sanjay S. Patel, Jason L. Weirather, Mikel Lipschitz, Ana Lako, Pei-Hsuan Chen ...
Blood blood.2019002206.
DOI: https://doi.org/10.1182/blood.2019002206
Published: 2019
Journal Articles

Pembrolizumab in relapsed or refractory Hodgkin lymphoma: 2-year follow-up of KEYNOTE-087

Clinical Trials & Observations
Robert Chen, Pier Luigi Zinzani, Hun Ju Lee, Philippe Armand, Nathalie A. Johnson ...
Blood (3 October 2019) 134 (14): 1144–1153.
DOI: https://doi.org/10.1182/blood.2019000324
Published: 2019
Includes: Supplemental data
Journal Articles

Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma

Brief Report
Matthew J. Frigault, Jorg Dietrich, Maria Martinez-Lage, Mark Leick, Bryan D. Choi ...
Blood (12 September 2019) 134 (11): 860–866.
DOI: https://doi.org/10.1182/blood.2019001694
Published: 2019
Includes: Supplemental data
Journal Articles

PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation

Clinical Trials & Observations
Philippe Armand, Yi-Bin Chen, Robert A. Redd, Robin M. Joyce, Jad Bsat ...
Blood (4 July 2019) 134 (1): 22–29.
DOI: https://doi.org/10.1182/blood.2019000215
Published: 2019
Journal Articles

Integrated Genetic and Topological Analysis Reveals a Hodgkin-like Mechanism of Immune Escape in T-Cell/Histiocyte-Rich Large B-Cell Lymphoma

Gabriel K Griffin, MD, Margaretha G.M. Roemer, PhD, Mikel Lipschitz, M.S., Jason Weirather, PhD, Christine J. Pak ...
Blood (29 November 2018) 132 (Supplement 1): 1579.
DOI: https://doi.org/10.1182/blood-2018-99-118610
Published: 2018
Journal Articles

A Phase 1b Study Investigating the Combination of the Tetravalent Bispecific NK Cell Engager AFM13 and Pembrolizumab in Patients with Relapsed/Refractory Hodgkin Lymphoma after Brentuximab Vedotin Failure: Updated Safety and Efficacy Data

Nancy L. Bartlett, MD, Robert W. Chen, MD, Eva Domingo-Domenech, MD, Andres Forero-Torres, MD, Ramon Garcia-Sanz, MD PhD ...
Blood (29 November 2018) 132 (Supplement 1): 1620.
DOI: https://doi.org/10.1182/blood-2018-99-118506
Published: 2018
Journal Articles

Procalcitonin As a Potential Biomarker for Differentiating Bacterial Infectious Fevers from Cytokine Release Syndrome

Joseph Maakaron, MD, Sam Penza, MD, Zeinab El Boghdadly, MBBCh, Caron A. Jacobson, MD, Bradley Hunter, MD MPH ...
Blood (29 November 2018) 132 (Supplement 1): 4216.
DOI: https://doi.org/10.1182/blood-2018-99-120065
Published: 2018
Journal Articles

Rituximab/Bendamustine and Rituximab/Cytarabine (RB/RC) Induction Chemotherapy for Transplant-Eligible Patients with Mantle Cell Lymphoma: A Pooled Analysis of Two Phase 2 Clinical Trials and Off-Trial Experience

Reid W Merryman, MD, Brad S Kahl, MD, Robert A. Redd, MS, Jad Bsat, BA, Matthew Lewis Chase ...
Blood (29 November 2018) 132 (Supplement 1): 145.
DOI: https://doi.org/10.1182/blood-2018-99-110520
Published: 2018
Journal Articles

Checkpoint Blockade Therapy May Sensitize Hodgkin Lymphoma to Subsequent Therapy

Nicole A Carreau, MD, Orrin Pail, MD, Philippe Armand, MD PhD, Reid W Merryman, MD, Ranjana H Advani, MD ...
Blood (29 November 2018) 132 (Supplement 1): 1626.
DOI: https://doi.org/10.1182/blood-2018-99-117672
Published: 2018
Journal Articles

Comprehensive Genomic Analysis of Flow-Sorted Hodgkin Reed Sternberg Cells Reveals Additional Genetic Bases of Immune Evasion

Kirsty Wienand, PhD, Bjoern Chapuy, MDPhD, Chip Stewart, PhD, Andrew Dunford, MS, David Wu, MD PhD ...
Blood (29 November 2018) 132 (Supplement 1): 1559.
DOI: https://doi.org/10.1182/blood-2018-99-118453
Published: 2018
Journal Articles

PD-1 Blockade with Pembrolizumab for Classical Hodgkin Lymphoma after Autologous Stem Cell Transplantation

Philippe Armand, MD PhD, Yi-Bin Chen, MD, Robert A. Redd, MS, Robin M. Joyce, MD, Jad Bsat, BA ...
Blood (29 November 2018) 132 (Supplement 1): 1650.
DOI: https://doi.org/10.1182/blood-2018-99-113685
Published: 2018
Journal Articles

A Phase II Study of Brentuximab Vedotin Plus Adriamycin and Dacarbazine without Radiation in Non-Bulky Limited Stage Classical Hodgkin Lymphoma

Jeremy S. Abramson, MD MMSc, Robert A. Redd, MS, Jeffrey A. Barnes, MD PhD, Elizabeth Bengtson, MD, Ronald W. Takvorian, MD ...
Blood (29 November 2018) 132 (Supplement 1): 1654.
DOI: https://doi.org/10.1182/blood-2018-99-115173
Published: 2018
Journal Articles

Allogeneic Stem Cell Transplantation Provides Durable Remission in Patients with Primary Mediastinal Large B-Cell Lymphoma

Alex F. Herrera, MD, Lu Chen, PhD, Sirin Khajavian, MD, Matthew Lewis Chase, Justin Darrah, MD ...
Blood (29 November 2018) 132 (Supplement 1): 2177.
DOI: https://doi.org/10.1182/blood-2018-99-114155
Published: 2018
Journal Articles

Pembrolizumab in Patients with Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma (PMBCL): Data from the Keynote-013 and Keynote-170 Studies

Philippe Armand, MD PhD, Scott J Rodig, MDPhD, Vladimir Melnichenko, Catherine Thieblemont, MD, Krimo Bouabdallah, MD ...
Blood (29 November 2018) 132 (Supplement 1): 228.
DOI: https://doi.org/10.1182/blood-2018-99-110220
Published: 2018
Journal Articles

Nivolumab Treatment Beyond Investigator-Assessed Progression: Extended Follow-up in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma from the Phase 2 CheckMate 205 Study

Jonathon B. Cohen, MDMS, John Kuruvilla, MD, Andreas Engert, MD, Stephen M. Ansell, MD PhD, Anas Younes, MD ...
Blood (29 November 2018) 132 (Supplement 1): 2932.
DOI: https://doi.org/10.1182/blood-2018-99-114502
Published: 2018
Journal Articles

Nivolumab for Relapsed or Refractory Classical Hodgkin Lymphoma (cHL) after Autologous Hematopoietic Cell Transplantation (auto-HCT): Extended Follow-up of the Phase 2 Single-Arm CheckMate 205 Study

Philippe Armand, MD PhD, Andreas Engert, MD, Anas Younes, MD, Hun Ju Lee, MD, Armando Santoro, MD ...
Blood (29 November 2018) 132 (Supplement 1): 2897.
DOI: https://doi.org/10.1182/blood-2018-99-112067
Published: 2018
Journal Articles

Two-Year Follow-up of Keynote-087 Study: Pembrolizumab Monotherapy in Relapsed/Refractory Classic Hodgkin Lymphoma

Pier Luigi Zinzani, MD, Robert W. Chen, MD, Hun Ju Lee, MD, Philippe Armand, MD PhD, Nathalie A Johnson, MD PhD ...
Blood (29 November 2018) 132 (Supplement 1): 2900.
DOI: https://doi.org/10.1182/blood-2018-99-117045
Published: 2018
Journal Articles

Axicabtagene Ciloleucel in the Real World: Outcomes and Predictors of Response, Resistance and Toxicity

Caron A. Jacobson, MD, Bradley Hunter, MD MPH, Philippe Armand, MD PhD, Yusuke Kamihara, MD PhD, Jerome Ritz, MD PhD ...
Blood (29 November 2018) 132 (Supplement 1): 92.
DOI: https://doi.org/10.1182/blood-2018-99-117199
Published: 2018
Journal Articles

A Phase I/Ib Study of Nivolumab for Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation (alloHCT)

Matthew S. Davids, MD, Haesook T. Kim, PhD, Caitlin L. Costello, MD, Alex F. Herrera, MD, Frederick L. Locke, MD ...
Blood (29 November 2018) 132 (Supplement 1): 705.
DOI: https://doi.org/10.1182/blood-2018-99-117671
Published: 2018
Journal Articles

PD-1 Blockade for Diffuse Large B-Cell Lymphoma after Autologous Stem Cell Transplantation

Yi-Bin Chen, MD, Philippe Armand, MD PhD, Robert A. Redd, MS, Jad Bsat, BA, Reid W Merryman, MD ...
Blood (29 November 2018) 132 (Supplement 1): 706.
DOI: https://doi.org/10.1182/blood-2018-99-114914
Published: 2018